rt-qpcr data statistical analyses Search Results


90
GraphPad Software Inc elisa
Elisa, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
elisa - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc multiple t-test in graphpad prism 8.0.2
Multiple T Test In Graphpad Prism 8.0.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multiple t-test in graphpad prism 8.0.2/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
multiple t-test in graphpad prism 8.0.2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
SAS institute proc glm procedure in sas v9.4
Proc Glm Procedure In Sas V9.4, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proc glm procedure in sas v9.4/product/SAS institute
Average 90 stars, based on 1 article reviews
proc glm procedure in sas v9.4 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

86
Thermo Fisher 7500 software v2 0
7500 Software V2 0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/7500 software v2 0/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
7500 software v2 0 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
SPSS Inc 17.0 software
17.0 Software, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/17.0 software/product/SPSS Inc
Average 90 stars, based on 1 article reviews
17.0 software - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
RStudio rstudio version 2022.07.0
Rstudio Version 2022.07.0, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rstudio version 2022.07.0/product/RStudio
Average 90 stars, based on 1 article reviews
rstudio version 2022.07.0 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Biogazelle rt-qpcr data analysis
Rt Qpcr Data Analysis, supplied by Biogazelle, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt-qpcr data analysis/product/Biogazelle
Average 90 stars, based on 1 article reviews
rt-qpcr data analysis - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Qiagen mirna rt-qpcr analysis
The expression of miR-378a-3p and miR-378d in serum exosomes is increased in breast cancer patients receiving chemotherapy and associated with chemoresistance. a Scanning electron microscopy of serum-exosomes isolated from patient serum. b Western blot analysis of the key enriched proteins CD81 and TSG101 in breast cancer patient serum exosomes. c Sequencing analysis of exosomal <t>microRNAs</t> from patient serum exosomes before receiving neoadjuvant chemotherapy, after receiving one cycle of neoadjuvant chemotherapy and after receiving four cycles of neoadjuvant chemotherapy. d Exosomes were isolated from the serum of breast cancer patients before and after neoadjuvant chemotherapy ( n = 24). Variation in serum exosomal miR-378a-3p and miR-378d in groups with different responses to neoadjuvant chemotherapy. e Five-year survival rates in patients with low or high expression miR-378 based on the TCGA database ( n = 854). f Analysis of miR-378 expression and the corresponding novel stemness index mRNAsi in 673 breast cancer patients in the TCGA database. g Pre- and post-chemotherapy expression data were analyzed by Gene set variation analysis for the breast cancer cohort ( n = 10). h Western blot analysis of protein expression in breast cancer tissue before and after neoadjuvant chemotherapy in the no response group ( n = 12). i The expression level of miR-378 was positively correlated with β-catenin , NOTCH1 or EZH2 in breast cancer ( n = 470). * p < 0.05, ** p < 0.01, *** p < 0.001
Mirna Rt Qpcr Analysis, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mirna rt-qpcr analysis/product/Qiagen
Average 90 stars, based on 1 article reviews
mirna rt-qpcr analysis - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

98
Bio-Rad cfx manager 3 0 software
The expression of miR-378a-3p and miR-378d in serum exosomes is increased in breast cancer patients receiving chemotherapy and associated with chemoresistance. a Scanning electron microscopy of serum-exosomes isolated from patient serum. b Western blot analysis of the key enriched proteins CD81 and TSG101 in breast cancer patient serum exosomes. c Sequencing analysis of exosomal <t>microRNAs</t> from patient serum exosomes before receiving neoadjuvant chemotherapy, after receiving one cycle of neoadjuvant chemotherapy and after receiving four cycles of neoadjuvant chemotherapy. d Exosomes were isolated from the serum of breast cancer patients before and after neoadjuvant chemotherapy ( n = 24). Variation in serum exosomal miR-378a-3p and miR-378d in groups with different responses to neoadjuvant chemotherapy. e Five-year survival rates in patients with low or high expression miR-378 based on the TCGA database ( n = 854). f Analysis of miR-378 expression and the corresponding novel stemness index mRNAsi in 673 breast cancer patients in the TCGA database. g Pre- and post-chemotherapy expression data were analyzed by Gene set variation analysis for the breast cancer cohort ( n = 10). h Western blot analysis of protein expression in breast cancer tissue before and after neoadjuvant chemotherapy in the no response group ( n = 12). i The expression level of miR-378 was positively correlated with β-catenin , NOTCH1 or EZH2 in breast cancer ( n = 470). * p < 0.05, ** p < 0.01, *** p < 0.001
Cfx Manager 3 0 Software, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cfx manager 3 0 software/product/Bio-Rad
Average 98 stars, based on 1 article reviews
cfx manager 3 0 software - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

90
GraphPad Software Inc prism 7.00
The expression of miR-378a-3p and miR-378d in serum exosomes is increased in breast cancer patients receiving chemotherapy and associated with chemoresistance. a Scanning electron microscopy of serum-exosomes isolated from patient serum. b Western blot analysis of the key enriched proteins CD81 and TSG101 in breast cancer patient serum exosomes. c Sequencing analysis of exosomal <t>microRNAs</t> from patient serum exosomes before receiving neoadjuvant chemotherapy, after receiving one cycle of neoadjuvant chemotherapy and after receiving four cycles of neoadjuvant chemotherapy. d Exosomes were isolated from the serum of breast cancer patients before and after neoadjuvant chemotherapy ( n = 24). Variation in serum exosomal miR-378a-3p and miR-378d in groups with different responses to neoadjuvant chemotherapy. e Five-year survival rates in patients with low or high expression miR-378 based on the TCGA database ( n = 854). f Analysis of miR-378 expression and the corresponding novel stemness index mRNAsi in 673 breast cancer patients in the TCGA database. g Pre- and post-chemotherapy expression data were analyzed by Gene set variation analysis for the breast cancer cohort ( n = 10). h Western blot analysis of protein expression in breast cancer tissue before and after neoadjuvant chemotherapy in the no response group ( n = 12). i The expression level of miR-378 was positively correlated with β-catenin , NOTCH1 or EZH2 in breast cancer ( n = 470). * p < 0.05, ** p < 0.01, *** p < 0.001
Prism 7.00, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism 7.00/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism 7.00 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher viia-7 qpcr instrument
The expression of miR-378a-3p and miR-378d in serum exosomes is increased in breast cancer patients receiving chemotherapy and associated with chemoresistance. a Scanning electron microscopy of serum-exosomes isolated from patient serum. b Western blot analysis of the key enriched proteins CD81 and TSG101 in breast cancer patient serum exosomes. c Sequencing analysis of exosomal <t>microRNAs</t> from patient serum exosomes before receiving neoadjuvant chemotherapy, after receiving one cycle of neoadjuvant chemotherapy and after receiving four cycles of neoadjuvant chemotherapy. d Exosomes were isolated from the serum of breast cancer patients before and after neoadjuvant chemotherapy ( n = 24). Variation in serum exosomal miR-378a-3p and miR-378d in groups with different responses to neoadjuvant chemotherapy. e Five-year survival rates in patients with low or high expression miR-378 based on the TCGA database ( n = 854). f Analysis of miR-378 expression and the corresponding novel stemness index mRNAsi in 673 breast cancer patients in the TCGA database. g Pre- and post-chemotherapy expression data were analyzed by Gene set variation analysis for the breast cancer cohort ( n = 10). h Western blot analysis of protein expression in breast cancer tissue before and after neoadjuvant chemotherapy in the no response group ( n = 12). i The expression level of miR-378 was positively correlated with β-catenin , NOTCH1 or EZH2 in breast cancer ( n = 470). * p < 0.05, ** p < 0.01, *** p < 0.001
Viia 7 Qpcr Instrument, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/viia-7 qpcr instrument/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
viia-7 qpcr instrument - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

99
fluidigm hd system
The expression of miR-378a-3p and miR-378d in serum exosomes is increased in breast cancer patients receiving chemotherapy and associated with chemoresistance. a Scanning electron microscopy of serum-exosomes isolated from patient serum. b Western blot analysis of the key enriched proteins CD81 and TSG101 in breast cancer patient serum exosomes. c Sequencing analysis of exosomal <t>microRNAs</t> from patient serum exosomes before receiving neoadjuvant chemotherapy, after receiving one cycle of neoadjuvant chemotherapy and after receiving four cycles of neoadjuvant chemotherapy. d Exosomes were isolated from the serum of breast cancer patients before and after neoadjuvant chemotherapy ( n = 24). Variation in serum exosomal miR-378a-3p and miR-378d in groups with different responses to neoadjuvant chemotherapy. e Five-year survival rates in patients with low or high expression miR-378 based on the TCGA database ( n = 854). f Analysis of miR-378 expression and the corresponding novel stemness index mRNAsi in 673 breast cancer patients in the TCGA database. g Pre- and post-chemotherapy expression data were analyzed by Gene set variation analysis for the breast cancer cohort ( n = 10). h Western blot analysis of protein expression in breast cancer tissue before and after neoadjuvant chemotherapy in the no response group ( n = 12). i The expression level of miR-378 was positively correlated with β-catenin , NOTCH1 or EZH2 in breast cancer ( n = 470). * p < 0.05, ** p < 0.01, *** p < 0.001
Hd System, supplied by fluidigm, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hd system/product/fluidigm
Average 99 stars, based on 1 article reviews
hd system - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


The expression of miR-378a-3p and miR-378d in serum exosomes is increased in breast cancer patients receiving chemotherapy and associated with chemoresistance. a Scanning electron microscopy of serum-exosomes isolated from patient serum. b Western blot analysis of the key enriched proteins CD81 and TSG101 in breast cancer patient serum exosomes. c Sequencing analysis of exosomal microRNAs from patient serum exosomes before receiving neoadjuvant chemotherapy, after receiving one cycle of neoadjuvant chemotherapy and after receiving four cycles of neoadjuvant chemotherapy. d Exosomes were isolated from the serum of breast cancer patients before and after neoadjuvant chemotherapy ( n = 24). Variation in serum exosomal miR-378a-3p and miR-378d in groups with different responses to neoadjuvant chemotherapy. e Five-year survival rates in patients with low or high expression miR-378 based on the TCGA database ( n = 854). f Analysis of miR-378 expression and the corresponding novel stemness index mRNAsi in 673 breast cancer patients in the TCGA database. g Pre- and post-chemotherapy expression data were analyzed by Gene set variation analysis for the breast cancer cohort ( n = 10). h Western blot analysis of protein expression in breast cancer tissue before and after neoadjuvant chemotherapy in the no response group ( n = 12). i The expression level of miR-378 was positively correlated with β-catenin , NOTCH1 or EZH2 in breast cancer ( n = 470). * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling

doi: 10.1186/s13046-021-01901-1

Figure Lengend Snippet: The expression of miR-378a-3p and miR-378d in serum exosomes is increased in breast cancer patients receiving chemotherapy and associated with chemoresistance. a Scanning electron microscopy of serum-exosomes isolated from patient serum. b Western blot analysis of the key enriched proteins CD81 and TSG101 in breast cancer patient serum exosomes. c Sequencing analysis of exosomal microRNAs from patient serum exosomes before receiving neoadjuvant chemotherapy, after receiving one cycle of neoadjuvant chemotherapy and after receiving four cycles of neoadjuvant chemotherapy. d Exosomes were isolated from the serum of breast cancer patients before and after neoadjuvant chemotherapy ( n = 24). Variation in serum exosomal miR-378a-3p and miR-378d in groups with different responses to neoadjuvant chemotherapy. e Five-year survival rates in patients with low or high expression miR-378 based on the TCGA database ( n = 854). f Analysis of miR-378 expression and the corresponding novel stemness index mRNAsi in 673 breast cancer patients in the TCGA database. g Pre- and post-chemotherapy expression data were analyzed by Gene set variation analysis for the breast cancer cohort ( n = 10). h Western blot analysis of protein expression in breast cancer tissue before and after neoadjuvant chemotherapy in the no response group ( n = 12). i The expression level of miR-378 was positively correlated with β-catenin , NOTCH1 or EZH2 in breast cancer ( n = 470). * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: The data after subsequent miRNA RT-qPCR analysis (Qiagen, USA) were standardized at the level of this spiked control.

Techniques: Expressing, Electron Microscopy, Isolation, Western Blot, Sequencing

Chemo-elicited exosomal miR-378a-3p and miR-378d regulated the WNT/β-catenin and Notch stemness pathways by targeting NUMB and DKK3. a Analysis of miRNA-378 expression data by Gene set enrichment analysis revealed that genes involved in the WNT and NOTCH pathways were significantly enriched. b MiRanda prediction of the binding sites of miR-378a-3p/miR-378d within the 3′-UTR of DKK3/NUMB . c , d Relative levels of DKK3/NUMB mRNA in CAL51 cells transfected with miR-378a-3p or miR-378d mimics and the corresponding normal control. e–h MiR-378a-3p/miR-378d was found to be directly bound to the NUMB/DKK3 3′-UTR using a dual-luciferase reporter assay. i, j Western blot analysis of the expression of DKK3, β-catenin, Cyclin D1, C-MYC, NUMB, NOTCH1, HES1 and HEY1 in the different groups. i CAL51 and MDA231 cells were transfected with miR-378a-3p or miR-378d mimics, inhibitors and the corresponding normal control for 48 h before western blot analysis. j Western blot results showing the expression levels of the indicated proteins in CAL51 and MDA231 cells at 48 h after simultaneous transfection with the DKK3 or NUMB expression plasmid or empty vector and miR-378a-3p or miR-378d mimics or the corresponding normal control. * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling

doi: 10.1186/s13046-021-01901-1

Figure Lengend Snippet: Chemo-elicited exosomal miR-378a-3p and miR-378d regulated the WNT/β-catenin and Notch stemness pathways by targeting NUMB and DKK3. a Analysis of miRNA-378 expression data by Gene set enrichment analysis revealed that genes involved in the WNT and NOTCH pathways were significantly enriched. b MiRanda prediction of the binding sites of miR-378a-3p/miR-378d within the 3′-UTR of DKK3/NUMB . c , d Relative levels of DKK3/NUMB mRNA in CAL51 cells transfected with miR-378a-3p or miR-378d mimics and the corresponding normal control. e–h MiR-378a-3p/miR-378d was found to be directly bound to the NUMB/DKK3 3′-UTR using a dual-luciferase reporter assay. i, j Western blot analysis of the expression of DKK3, β-catenin, Cyclin D1, C-MYC, NUMB, NOTCH1, HES1 and HEY1 in the different groups. i CAL51 and MDA231 cells were transfected with miR-378a-3p or miR-378d mimics, inhibitors and the corresponding normal control for 48 h before western blot analysis. j Western blot results showing the expression levels of the indicated proteins in CAL51 and MDA231 cells at 48 h after simultaneous transfection with the DKK3 or NUMB expression plasmid or empty vector and miR-378a-3p or miR-378d mimics or the corresponding normal control. * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: The data after subsequent miRNA RT-qPCR analysis (Qiagen, USA) were standardized at the level of this spiked control.

Techniques: Expressing, Binding Assay, Transfection, Control, Luciferase, Reporter Assay, Western Blot, Plasmid Preparation